Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1972-4-7
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0028-4793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
286
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
470-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4550616-Allopurinol,
pubmed-meshheading:4550616-Gout,
pubmed-meshheading:4550616-Humans,
pubmed-meshheading:4550616-Kidney,
pubmed-meshheading:4550616-Purine-Pyrimidine Metabolism, Inborn Errors,
pubmed-meshheading:4550616-Purines,
pubmed-meshheading:4550616-Uric Acid,
pubmed-meshheading:4550616-Uricosuric Agents
|
pubmed:year |
1972
|
pubmed:articleTitle |
The physiologic approach to hyperuricemia.
|
pubmed:publicationType |
Journal Article,
Review
|